ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Encephalitis Vaccination Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-S11
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Encephalitis Vaccination Market Size Status and Forecast 2019 2025
BUY CHAPTERS

Global Encephalitis Vaccination Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-S11
Report
June 2025
Pages:139
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Sanofi
Beijing Taitan
Valneva
Bharat Biotech
Liaoning Chengda
Chengdu Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products

Encephalitis Vaccination Market Size

In 2024, the global market size of Encephalitis Vaccination was estimated to be worth US$ 1439 million and is forecast to reach approximately US$ 2096 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.

Encephalitis Vaccination Market

Encephalitis Vaccination Market

Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.
The world"s leading manufacturers of JE vaccines are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Encephalitis Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Encephalitis Vaccination.
The Encephalitis Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Encephalitis Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Encephalitis Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Encephalitis Vaccination Market Report

Report Metric Details
Report Name Encephalitis Vaccination Market
Forecasted market size in 2031 approximately US$ 2096 million
CAGR 5.6%
Forecasted years 2025 - 2031
Segment by Type
  • Encephalitis B Vaccine
  • Encephalitis Attenuated Live Vaccine
Segment by Application
  • Public Hospital
  • Private Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech, Liaoning Chengda
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Encephalitis Vaccination in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Encephalitis Vaccination manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Encephalitis Vaccination sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Encephalitis Vaccination Market size in 2031?

Ans: The Encephalitis Vaccination Market size in 2031 will be approximately US$ 2096 million.

Who are the main players in the Encephalitis Vaccination Market report?

Ans: The main players in the Encephalitis Vaccination Market are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech, Liaoning Chengda

What are the Application segmentation covered in the Encephalitis Vaccination Market report?

Ans: The Applications covered in the Encephalitis Vaccination Market report are Public Hospital, Private Hospital, Clinic, Other

What are the Type segmentation covered in the Encephalitis Vaccination Market report?

Ans: The Types covered in the Encephalitis Vaccination Market report are Encephalitis B Vaccine, Encephalitis Attenuated Live Vaccine

1 Study Coverage
1.1 Encephalitis Vaccination Product Introduction
1.2 Market by Type
1.2.1 Global Encephalitis Vaccination Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Encephalitis B Vaccine
1.2.3 Encephalitis Attenuated Live Vaccine
1.3 Market by Application
1.3.1 Global Encephalitis Vaccination Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Public Hospital
1.3.3 Private Hospital
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Encephalitis Vaccination Market Size Estimates and Forecasts
2.1.1 Global Encephalitis Vaccination Revenue 2020-2031
2.1.2 Global Encephalitis Vaccination Sales 2020-2031
2.2 Encephalitis Vaccination Market Size by Region: 2024 Versus 2031
2.3 Encephalitis Vaccination Sales by Region (2020-2031)
2.3.1 Global Encephalitis Vaccination Sales by Region: 2020-2025
2.3.2 Global Encephalitis Vaccination Sales Forecast by Region (2026-2031)
2.3.3 Global Encephalitis Vaccination Sales Market Share by Region (2020-2031)
2.4 Encephalitis Vaccination Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Encephalitis Vaccination Revenue by Region: 2020-2025
2.4.2 Global Encephalitis Vaccination Revenue Forecast by Region (2026-2031)
2.4.3 Global Encephalitis Vaccination Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Encephalitis Vaccination Sales by Type (2020-2031)
3.1.1.1 Global Encephalitis Vaccination Sales Volume by Type (2020-2031)
3.1.1.2 Global Encephalitis Vaccination Sales Market Share by Type (2020-2031)
3.1.2 Global Encephalitis Vaccination Revenue by Type (2020-2031)
3.1.2.1 Global Encephalitis Vaccination Revenue by Type (2020-2031)
3.1.2.2 Global Encephalitis Vaccination Revenue Market Share by Type (2020-2031)
3.1.3 Encephalitis Vaccination Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Encephalitis Vaccination Sales by Application (2020-2031)
3.2.1.1 Global Encephalitis Vaccination Sales Volume by Application (2020-2031)
3.2.1.2 Global Encephalitis Vaccination Sales Market Share by Application (2020-2031)
3.2.2 Global Encephalitis Vaccination Revenue by Application (2020-2031)
3.2.2.1 Global Encephalitis Vaccination Revenue by Application (2020-2031)
3.2.2.2 Global Encephalitis Vaccination Revenue Market Share by Application (2020-2031)
3.2.3 Encephalitis Vaccination Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Encephalitis B Vaccine of Encephalitis Vaccination Revenue Market Share by Application
3.3.2 Encephalitis Attenuated Live Vaccine of Encephalitis Vaccination Revenue Market Share by Application
4 Global Encephalitis Vaccination by Manufacturers
4.1 Global Top Encephalitis Vaccination Manufacturers by Sales (2020-2025)
4.1.1 Global Encephalitis Vaccination Sales by Manufacturer (2020-2025)
4.1.2 Global Encephalitis Vaccination Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Encephalitis Vaccination Manufacturers by Revenue (2020-2025)
4.2.1 Global Encephalitis Vaccination Revenue by Manufacturer (2020-2025)
4.2.2 Global Encephalitis Vaccination Revenue Share by Manufacturer (2020-2025)
4.3 Global Encephalitis Vaccination Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Encephalitis Vaccination Manufacturers Covered: Ranking by Revenue
4.4.2 Global Encephalitis Vaccination Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Encephalitis Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Encephalitis Vaccination Manufacturing Base Distribution, Product Type
4.5.1 Encephalitis Vaccination Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Encephalitis Vaccination Market
4.5.3 Manufacturers Encephalitis Vaccination Product Type and Application
4.5.4 Encephalitis B Vaccine Market Sales of Encephalitis Vaccination by Manufacturer
4.5.5 Encephalitis Attenuated Live Vaccine Market Sales of Encephalitis Vaccination by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Novartis
5.1.1 Novartis Company Information
5.1.2 Novartis Description, Business Overview
5.1.3 Novartis Encephalitis Vaccination Products Offered
5.1.4 Novartis Encephalitis Vaccination Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Novartis Encephalitis Vaccination Sales by Product in 2024
5.1.6 Novartis Encephalitis Vaccination Sales by Application in 2024
5.1.7 Novartis Encephalitis Vaccination Sales by Geographic Area in 2024
5.1.8 Novartis Recent Developments
5.2 Sanofi
5.2.1 Sanofi Company Information
5.2.2 Sanofi Description, Business Overview
5.2.3 Sanofi Encephalitis Vaccination Products Offered
5.2.4 Sanofi Encephalitis Vaccination Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Sanofi Encephalitis Vaccination Sales by Product in 2024
5.2.6 Sanofi Encephalitis Vaccination Sales by Application in 2024
5.2.7 Sanofi Encephalitis Vaccination Sales by Geographic Area in 2024
5.2.8 Sanofi Recent Developments
5.3 Chengdu Institute of Biological Products
5.3.1 Chengdu Institute of Biological Products Company Information
5.3.2 Chengdu Institute of Biological Products Description, Business Overview
5.3.3 Chengdu Institute of Biological Products Encephalitis Vaccination Products Offered
5.3.4 Chengdu Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Chengdu Institute of Biological Products Encephalitis Vaccination Sales by Product in 2024
5.3.6 Chengdu Institute of Biological Products Encephalitis Vaccination Sales by Application in 2024
5.3.7 Chengdu Institute of Biological Products Encephalitis Vaccination Sales by Geographic Area in 2024
5.3.8 Chengdu Institute of Biological Products Recent Developments
5.4 Wuhan Institute of Biological Products
5.4.1 Wuhan Institute of Biological Products Company Information
5.4.2 Wuhan Institute of Biological Products Description, Business Overview
5.4.3 Wuhan Institute of Biological Products Encephalitis Vaccination Products Offered
5.4.4 Wuhan Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Wuhan Institute of Biological Products Encephalitis Vaccination Sales by Product in 2024
5.4.6 Wuhan Institute of Biological Products Encephalitis Vaccination Sales by Application in 2024
5.4.7 Wuhan Institute of Biological Products Encephalitis Vaccination Sales by Geographic Area in 2024
5.4.8 Wuhan Institute of Biological Products Recent Developments
5.5 Lanzhou Institute of Biological Products
5.5.1 Lanzhou Institute of Biological Products Company Information
5.5.2 Lanzhou Institute of Biological Products Description, Business Overview
5.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccination Products Offered
5.5.4 Lanzhou Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Lanzhou Institute of Biological Products Encephalitis Vaccination Sales by Product in 2024
5.5.6 Lanzhou Institute of Biological Products Encephalitis Vaccination Sales by Application in 2024
5.5.7 Lanzhou Institute of Biological Products Encephalitis Vaccination Sales by Geographic Area in 2024
5.5.8 Lanzhou Institute of Biological Products Recent Developments
5.6 Beijing Taitan
5.6.1 Beijing Taitan Company Information
5.6.2 Beijing Taitan Description, Business Overview
5.6.3 Beijing Taitan Encephalitis Vaccination Products Offered
5.6.4 Beijing Taitan Encephalitis Vaccination Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Beijing Taitan Encephalitis Vaccination Sales by Product in 2024
5.6.6 Beijing Taitan Encephalitis Vaccination Sales by Application in 2024
5.6.7 Beijing Taitan Encephalitis Vaccination Sales by Geographic Area in 2024
5.6.8 Beijing Taitan Recent Developments
5.7 Valneva
5.7.1 Valneva Company Information
5.7.2 Valneva Description, Business Overview
5.7.3 Valneva Encephalitis Vaccination Products Offered
5.7.4 Valneva Encephalitis Vaccination Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Valneva Encephalitis Vaccination Sales by Product in 2024
5.7.6 Valneva Encephalitis Vaccination Sales by Application in 2024
5.7.7 Valneva Encephalitis Vaccination Sales by Geographic Area in 2024
5.7.8 Valneva Recent Developments
5.8 Bharat Biotech
5.8.1 Bharat Biotech Company Information
5.8.2 Bharat Biotech Description, Business Overview
5.8.3 Bharat Biotech Encephalitis Vaccination Products Offered
5.8.4 Bharat Biotech Encephalitis Vaccination Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Bharat Biotech Encephalitis Vaccination Sales by Product in 2024
5.8.6 Bharat Biotech Encephalitis Vaccination Sales by Application in 2024
5.8.7 Bharat Biotech Encephalitis Vaccination Sales by Geographic Area in 2024
5.8.8 Bharat Biotech Recent Developments
5.9 Liaoning Chengda
5.9.1 Liaoning Chengda Company Information
5.9.2 Liaoning Chengda Description, Business Overview
5.9.3 Liaoning Chengda Encephalitis Vaccination Products Offered
5.9.4 Liaoning Chengda Encephalitis Vaccination Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Liaoning Chengda Encephalitis Vaccination Sales by Product in 2024
5.9.6 Liaoning Chengda Encephalitis Vaccination Sales by Application in 2024
5.9.7 Liaoning Chengda Encephalitis Vaccination Sales by Geographic Area in 2024
5.9.8 Liaoning Chengda Recent Developments
6 North America
6.1 North America Encephalitis Vaccination Market Size YoY Growth 2020-2031
6.2 North America Encephalitis Vaccination Market Facts & Figures by Country
6.2.1 North America Encephalitis Vaccination Sales by Country (2020-2031)
6.2.2 North America Encephalitis Vaccination Revenue by Country (2020-2031)
6.3 North America Encephalitis Vaccination Sales by Type (2020-2025)
6.4 North America Encephalitis Vaccination Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Encephalitis Vaccination Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Encephalitis Vaccination Market Facts & Figures by Region
7.2.1 Asia-Pacific Encephalitis Vaccination Sales by Region (2020-2031)
7.2.2 Asia-Pacific Encephalitis Vaccination Revenue by Region (2020-2031)
7.3 Asia-Pacific Encephalitis Vaccination Sales by Type (2020-2025)
7.4 Asia-Pacific Encephalitis Vaccination Sales by Application (2020-2025)
8 Europe
8.1 Europe Encephalitis Vaccination Market Size YoY Growth 2020-2031
8.2 Europe Encephalitis Vaccination Market Facts & Figures by Country
8.2.1 Europe Encephalitis Vaccination Sales by Country (2020-2031)
8.2.2 Europe Encephalitis Vaccination Revenue by Country (2020-2031)
8.3 Europe Encephalitis Vaccination Sales by Type (2020-2025)
8.4 Europe Encephalitis Vaccination Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Encephalitis Vaccination Market Size YoY Growth 2020-2031
9.2 Latin America Encephalitis Vaccination Market Facts & Figures by Country
9.2.1 Latin America Encephalitis Vaccination Sales by Country (2020-2031)
9.2.2 Latin America Encephalitis Vaccination Revenue by Country (2020-2031)
9.3 Latin America Encephalitis Vaccination Sales by Type (2020-2025)
9.4 Latin America Encephalitis Vaccination Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Encephalitis Vaccination Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Encephalitis Vaccination Market Facts & Figures by Country
10.2.1 Middle East and Africa Encephalitis Vaccination Sales by Country (2020-2031)
10.2.2 Middle East and Africa Encephalitis Vaccination Revenue by Country (2020-2031)
10.3 Middle East and Africa Encephalitis Vaccination Sales by Type (2020-2025)
10.4 Middle East and Africa Encephalitis Vaccination Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Encephalitis Vaccination Supply Chain Analysis
11.2 Encephalitis Vaccination Key Raw Materials and Upstream Suppliers
11.3 Encephalitis Vaccination Clients Analysis
11.4 Encephalitis Vaccination Sales Channel and Sales Model Analysis
11.4.1 Encephalitis Vaccination Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Encephalitis Vaccination Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Encephalitis Vaccination Distributors
12 Encephalitis Vaccination Market Dynamics
12.1 Encephalitis Vaccination Industry Trends
12.2 Encephalitis Vaccination Market Drivers
12.3 Encephalitis Vaccination Market Challenges
12.4 Encephalitis Vaccination Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Novartis
Sanofi
Beijing Taitan
Valneva
Bharat Biotech
Liaoning Chengda
Chengdu Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
List of Tables
 Table 1. Global Encephalitis Vaccination Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Encephalitis Vaccination Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Encephalitis Vaccination Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Encephalitis Vaccination Sales by Region (2020-2025) & (K Units)
 Table 5. Global Encephalitis Vaccination Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Encephalitis Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Encephalitis Vaccination Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Encephalitis Vaccination Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Encephalitis Vaccination Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Encephalitis Vaccination Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Encephalitis Vaccination Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Encephalitis Vaccination Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Encephalitis Vaccination Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Encephalitis Vaccination Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Encephalitis Vaccination Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Encephalitis Vaccination Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Encephalitis Vaccination Sales Share by Manufacturer (2020-2025)
 Table 18. Encephalitis Vaccination Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Encephalitis Vaccination Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Encephalitis Vaccination Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Encephalitis Vaccination Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Encephalitis Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Encephalitis Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Encephalitis Vaccination as of 2024)
 Table 24. Encephalitis Vaccination Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Encephalitis Vaccination Market
 Table 26. Manufacturers Encephalitis Vaccination Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Novartis Company Information
 Table 29. Novartis Description and Business Overview
 Table 30. Novartis Encephalitis Vaccination Product
 Table 31. Novartis Encephalitis Vaccination Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Novartis Sales Proportion of Encephalitis Vaccination by Product in 2024
 Table 33. Novartis Sales Proportion of Encephalitis Vaccination by Application in 2024
 Table 34. Novartis Sales Proportion of Encephalitis Vaccination by Geographic Area in 2024
 Table 35. Novartis Recent Developments
 Table 36. Sanofi Company Information
 Table 37. Sanofi Description and Business Overview
 Table 38. Sanofi Encephalitis Vaccination Product
 Table 39. Sanofi Encephalitis Vaccination Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Sanofi Sales Proportion of Encephalitis Vaccination by Product in 2024
 Table 41. Sanofi Sales Proportion of Encephalitis Vaccination by Application in 2024
 Table 42. Sanofi Sales Proportion of Encephalitis Vaccination by Geographic Area in 2024
 Table 43. Sanofi Recent Developments
 Table 44. Chengdu Institute of Biological Products Company Information
 Table 45. Chengdu Institute of Biological Products Description and Business Overview
 Table 46. Chengdu Institute of Biological Products Encephalitis Vaccination Product
 Table 47. Chengdu Institute of Biological Products Encephalitis Vaccination Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Chengdu Institute of Biological Products Sales Proportion of Encephalitis Vaccination by Product in 2024
 Table 49. Chengdu Institute of Biological Products Sales Proportion of Encephalitis Vaccination by Application in 2024
 Table 50. Chengdu Institute of Biological Products Sales Proportion of Encephalitis Vaccination by Geographic Area in 2024
 Table 51. Chengdu Institute of Biological Products Recent Developments
 Table 52. Wuhan Institute of Biological Products Company Information
 Table 53. Wuhan Institute of Biological Products Description and Business Overview
 Table 54. Wuhan Institute of Biological Products Encephalitis Vaccination Product
 Table 55. Wuhan Institute of Biological Products Encephalitis Vaccination Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Wuhan Institute of Biological Products Sales Proportion of Encephalitis Vaccination by Product in 2024
 Table 57. Wuhan Institute of Biological Products Sales Proportion of Encephalitis Vaccination by Application in 2024
 Table 58. Wuhan Institute of Biological Products Sales Proportion of Encephalitis Vaccination by Geographic Area in 2024
 Table 59. Wuhan Institute of Biological Products Recent Developments
 Table 60. Lanzhou Institute of Biological Products Company Information
 Table 61. Lanzhou Institute of Biological Products Description and Business Overview
 Table 62. Lanzhou Institute of Biological Products Encephalitis Vaccination Product
 Table 63. Lanzhou Institute of Biological Products Encephalitis Vaccination Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Lanzhou Institute of Biological Products Sales Proportion of Encephalitis Vaccination by Product in 2024
 Table 65. Lanzhou Institute of Biological Products Sales Proportion of Encephalitis Vaccination by Application in 2024
 Table 66. Lanzhou Institute of Biological Products Sales Proportion of Encephalitis Vaccination by Geographic Area in 2024
 Table 67. Lanzhou Institute of Biological Products Recent Developments
 Table 68. Beijing Taitan Company Information
 Table 69. Beijing Taitan Description and Business Overview
 Table 70. Beijing Taitan Encephalitis Vaccination Product
 Table 71. Beijing Taitan Encephalitis Vaccination Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Beijing Taitan Sales Proportion of Encephalitis Vaccination by Product in 2024
 Table 73. Beijing Taitan Sales Proportion of Encephalitis Vaccination by Application in 2024
 Table 74. Beijing Taitan Sales Proportion of Encephalitis Vaccination by Geographic Area in 2024
 Table 75. Beijing Taitan Recent Developments
 Table 76. Valneva Company Information
 Table 77. Valneva Description and Business Overview
 Table 78. Valneva Encephalitis Vaccination Product
 Table 79. Valneva Encephalitis Vaccination Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Valneva Sales Proportion of Encephalitis Vaccination by Product in 2024
 Table 81. Valneva Sales Proportion of Encephalitis Vaccination by Application in 2024
 Table 82. Valneva Sales Proportion of Encephalitis Vaccination by Geographic Area in 2024
 Table 83. Valneva Recent Developments
 Table 84. Bharat Biotech Company Information
 Table 85. Bharat Biotech Description and Business Overview
 Table 86. Bharat Biotech Encephalitis Vaccination Product
 Table 87. Bharat Biotech Encephalitis Vaccination Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Bharat Biotech Sales Proportion of Encephalitis Vaccination by Product in 2024
 Table 89. Bharat Biotech Sales Proportion of Encephalitis Vaccination by Application in 2024
 Table 90. Bharat Biotech Sales Proportion of Encephalitis Vaccination by Geographic Area in 2024
 Table 91. Bharat Biotech Recent Developments
 Table 92. Liaoning Chengda Company Information
 Table 93. Liaoning Chengda Description and Business Overview
 Table 94. Liaoning Chengda Encephalitis Vaccination Product
 Table 95. Liaoning Chengda Encephalitis Vaccination Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Liaoning Chengda Sales Proportion of Encephalitis Vaccination by Product in 2024
 Table 97. Liaoning Chengda Sales Proportion of Encephalitis Vaccination by Application in 2024
 Table 98. Liaoning Chengda Sales Proportion of Encephalitis Vaccination by Geographic Area in 2024
 Table 99. Liaoning Chengda Recent Developments
 Table 100. North America Encephalitis Vaccination Sales by Country (2020-2025) & (K Units)
 Table 101. North America Encephalitis Vaccination Sales by Country (2026-2031) & (K Units)
 Table 102. North America Encephalitis Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 103. North America Encephalitis Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 104. North America Encephalitis Vaccination Sales by Type (2020-2025) & (K Units)
 Table 105. North America Encephalitis Vaccination Sales by Application (2020-2025) & (K Units)
 Table 106. Asia-Pacific Encephalitis Vaccination Sales by Region (2020-2025) & (K Units)
 Table 107. Asia-Pacific Encephalitis Vaccination Sales by Region (2026-2031) & (K Units)
 Table 108. Asia-Pacific Encephalitis Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 109. Asia-Pacific Encephalitis Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 110. Asia-Pacific Encephalitis Vaccination Sales by Type (2020-2025) & (K Units)
 Table 111. Asia-Pacific Encephalitis Vaccination Sales by Application (2020-2025) & (K Units)
 Table 112. Europe Encephalitis Vaccination Sales by Country (2020-2025) & (K Units)
 Table 113. Europe Encephalitis Vaccination Sales by Country (2026-2031) & (K Units)
 Table 114. Europe Encephalitis Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 115. Europe Encephalitis Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 116. Europe Encephalitis Vaccination Sales by Type (2020-2025) & (K Units)
 Table 117. Europe Encephalitis Vaccination Sales by Application (2020-2025) & (K Units)
 Table 118. Latin America Encephalitis Vaccination Sales by Country (2020-2025) & (K Units)
 Table 119. Latin America Encephalitis Vaccination Sales by Country (2026-2031) & (K Units)
 Table 120. Latin America Encephalitis Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 121. Latin America Encephalitis Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 122. Latin America Encephalitis Vaccination Sales by Type (2020-2025) & (K Units)
 Table 123. Latin America Encephalitis Vaccination Sales by Application (2020-2025) & (K Units)
 Table 124. Middle East and Africa Encephalitis Vaccination Sales by Country (2020-2025) & (K Units)
 Table 125. Middle East and Africa Encephalitis Vaccination Sales by Country (2026-2031) & (K Units)
 Table 126. Middle East and Africa Encephalitis Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 127. Middle East and Africa Encephalitis Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 128. Middle East and Africa Encephalitis Vaccination Sales by Type (2020-2025) & (K Units)
 Table 129. Middle East and Africa Encephalitis Vaccination Sales by Application (2020-2025) & (K Units)
 Table 130. Encephalitis Vaccination Key Raw Materials, Industry Status and Trend
 Table 131. Encephalitis Vaccination Key Raw Materials and Upstream Suppliers
 Table 132. Encephalitis Vaccination Clients Status and Trend
 Table 133. Encephalitis Vaccination Typical Clients
 Table 134. Encephalitis Vaccination Distributors
 Table 135. Encephalitis Vaccination Market Trends
 Table 136. Encephalitis Vaccination Market Drivers
 Table 137. Encephalitis Vaccination Market Challenges
 Table 138. Encephalitis Vaccination Market Restraints
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources
 Table 142. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Encephalitis Vaccination Product Picture
 Figure 2. Global Encephalitis Vaccination Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Encephalitis Vaccination Sales Market Share by Type in 2024 & 2031
 Figure 4. Encephalitis B Vaccine Product Picture
 Figure 5. Encephalitis Attenuated Live Vaccine Product Picture
 Figure 6. Global Encephalitis Vaccination Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Encephalitis Vaccination Sales Market Share by Application in 2024 & 2031
 Figure 8. Public Hospital
 Figure 9. Private Hospital
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Encephalitis Vaccination Report Years Considered
 Figure 13. Global Encephalitis Vaccination Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Encephalitis Vaccination Market Size 2020-2031 (US$ Million)
 Figure 15. Global Encephalitis Vaccination Sales 2020-2031 (K Units)
 Figure 16. Global Encephalitis Vaccination Sales Market Share Forecast by Region (2020-2031)
 Figure 17. Global Encephalitis Vaccination Revenue Market Share by Region (2020-2031)
 Figure 18. Global Encephalitis Vaccination Sales Market Share Forecast by Type (2020-2031)
 Figure 19. Global Encephalitis Vaccination Revenue Market Share Forecast by Type (2020-2031)
 Figure 20. Encephalitis Vaccination Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 21. Global Encephalitis Vaccination Sales Market Share Forecast by Application (2020-2031)
 Figure 22. Global Encephalitis Vaccination Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. Encephalitis Vaccination Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 24. Encephalitis B Vaccine of Encephalitis Vaccination Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Encephalitis Attenuated Live Vaccine of Encephalitis Vaccination Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Global Encephalitis Vaccination Sales Share by Manufacturer in 2024
 Figure 27. Encephalitis Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 28. Encephalitis B Vaccine Market Sales Proportion by Manufacturer in 2024
 Figure 29. Encephalitis Attenuated Live Vaccine Market Sales Proportion by Manufacturer in 2024
 Figure 30. North America Encephalitis Vaccination Revenue 2020-2031 (US$ Million)
 Figure 31. North America Encephalitis Vaccination Sales Market Share by Type (2020-2025)
 Figure 32. North America Encephalitis Vaccination Sales Market Share by Application (2020-2025)
 Figure 33. Asia-Pacific Encephalitis Vaccination Revenue 2020-2031 (US$ Million)
 Figure 34. Asia-Pacific Encephalitis Vaccination Sales Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Encephalitis Vaccination Revenue Market Share by Region (2020-2031)
 Figure 36. Asia-Pacific Encephalitis Vaccination Sales Market Share by Type (2020-2025)
 Figure 37. Asia-Pacific Encephalitis Vaccination Sales Market Share by Application (2020-2025)
 Figure 38. Europe Encephalitis Vaccination Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 39. Europe Encephalitis Vaccination Sales Market Share by Country (2020-2031)
 Figure 40. Europe Encephalitis Vaccination Revenue Market Share by Country (2020-2031)
 Figure 41. Europe Encephalitis Vaccination Sales Market Share by Type (2020-2025)
 Figure 42. Europe Encephalitis Vaccination Sales Market Share by Application (2020-2025)
 Figure 43. Latin America Encephalitis Vaccination Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 44. Latin America Encephalitis Vaccination Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Encephalitis Vaccination Revenue Market Share by Country (2020-2025)
 Figure 46. Latin America Encephalitis Vaccination Sales Market Share by Type (2020-2025)
 Figure 47. Latin America Encephalitis Vaccination Sales Market Share by Application (2020-2025)
 Figure 48. Middle East and Africa Encephalitis Vaccination Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Middle East and Africa Encephalitis Vaccination Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Encephalitis Vaccination Revenue Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Encephalitis Vaccination Sales Market Share by Type (2020-2025)
 Figure 52. Middle East and Africa Encephalitis Vaccination Sales Market Share by Application (2020-2025)
 Figure 53. Encephalitis Vaccination Supply Chain (Upstream and Downstream Market)
 Figure 54. Global Production Market Share of Encephalitis Vaccination Raw Materials by Region in 2024
 Figure 55. Encephalitis Vaccination Distribution Channels
 Figure 56. Global Encephalitis Vaccination Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 57. Global Encephalitis Vaccination Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Japanese Encephalitis Vaccines Market Research Report 2024
Live Attenuated Japanese Encephalitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Yellow Fever Vaccination Market Research Report 2025
Global Yellow Fever Vaccines Market Insights Forecast to 2030
Japanese Encephalitis Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tick borne Encephalitis Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Meningitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Epidemic Encephalitis Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tick borne Encephalitis Vaccine Market Research Report 2024
Encephalitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Japanese Encephalitis Inactivated Vaccine Market Research Report 2025
Animal Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Epidemic Diarrhea Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Porcine Epidemic Diarrhea Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Vaccination Market Research Report 2025
Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Vaccines Market Insights Forecast to 2030
Malaria Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
JE Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions